MEDIFAST INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Medifast Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Medifast Inc Return On Equity for the quarter ending September 30, 2024 was 3.55 %, a 94.8% decline year-over-year.
  • Medifast Inc annual Return On Equity for 2023 was 53 %, a 40% decline from 2022.
  • Medifast Inc annual Return On Equity for 2022 was 88.2 %, a 3.28% increase from 2021.
  • Medifast Inc annual Return On Equity for 2021 was 85.4 %, a 8.92% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 53 -35.3 -40% Jan 1, 2023 Dec 31, 2023
2022 88.2 +2.8 +3.28% Jan 1, 2022 Dec 31, 2022
2021 85.4 +6.99 +8.92% Jan 1, 2021 Dec 31, 2021
2020 78.4 +11.3 +16.8% Jan 1, 2020 Dec 31, 2020
2019 67.2 +16.1 +31.6% Jan 1, 2019 Dec 31, 2019
2018 51 +24.5 +92.5% Jan 1, 2018 Dec 31, 2018
2017 26.5 +7.35 +38.3% Jan 1, 2017 Dec 31, 2017
2016 19.2 -3.85 -16.7% Jan 1, 2016 Dec 31, 2016
2015 23 +8.61 +59.7% Jan 1, 2015 Dec 31, 2015
2014 14.4 -8.88 -38.1% Jan 1, 2014 Dec 31, 2014
2013 23.3 +4.37 +23.1% Jan 1, 2013 Dec 31, 2013
2012 18.9 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.